HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ANIP

ANI Pharmaceuticals, Inc. (NASDAQ)

Healthcare — Drug Manufacturers - Specialty & Generic

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

None 7 analysts
$82.78
$0.27 (-1.59%)
Target: $112.71 (36.2%)
Sign in to add ANIP to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$1.88B
P/E Ratio (TTM)21.13
Forward P/E7.73
EPS (TTM)$3.91
Dividend Yield-
Profit Margin9.98%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation None
Analyst Target$112.71
Analysts7
Indexes NASDAQ

Technical Indicators

RSI (14)56.1
Beta0.44
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume-
Volume-

Performance Analysis

BULLISH

ANIP shows predominantly bullish signals based on its fundamentals and technicals.

+ RSI at 56.1 shows positive momentum.
~ Wall Street consensus is "none" from 7 analysts.
+ Average analyst target of $112.71 implies 36.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 11:46 UTC

Back to Screener Export Report